- Home
- MRNA vs GMED Comparison
MRNA vs GMED Comparison
Compare MRNA & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- GMED
- Stock Information
- Founded
- MRNA 2010
- GMED 2003
- Country
- MRNA United States
- GMED United States
- Employees
- MRNA N/A
- GMED N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- GMED Medical/Dental Instruments
- Sector
- MRNA Health Care
- GMED Health Care
- Exchange
- MRNA Nasdaq
- GMED Nasdaq
- Market Cap
- MRNA 10.6B
- GMED 9.6B
- IPO Year
- MRNA 2018
- GMED 2012
- Fundamental
- Price
- MRNA $26.56
- GMED $59.22
- Analyst Decision
- MRNA Hold
- GMED Buy
- Analyst Count
- MRNA 19
- GMED 13
- Target Price
- MRNA $48.13
- GMED $94.30
- AVG Volume (30 Days)
- MRNA 14.2M
- GMED 2.2M
- Earning Date
- MRNA 05-01-2025
- GMED 05-08-2025
- Dividend Yield
- MRNA N/A
- GMED N/A
- EPS Growth
- MRNA N/A
- GMED 145.70
- EPS
- MRNA N/A
- GMED 1.34
- Revenue
- MRNA $3,177,000,000.00
- GMED $2,510,810,000.00
- Revenue This Year
- MRNA N/A
- GMED $14.43
- Revenue Next Year
- MRNA $8.98
- GMED $9.40
- P/E Ratio
- MRNA N/A
- GMED $44.30
- Revenue Growth
- MRNA N/A
- GMED 32.26
- 52 Week Low
- MRNA $23.15
- GMED $54.48
- 52 Week High
- MRNA $158.82
- GMED $94.93
- Technical
- Relative Strength Index (RSI)
- MRNA 50.60
- GMED 37.49
- Support Level
- MRNA $25.22
- GMED $57.14
- Resistance Level
- MRNA $27.15
- GMED $60.10
- Average True Range (ATR)
- MRNA 1.61
- GMED 1.58
- MACD
- MRNA 0.26
- GMED 0.16
- Stochastic Oscillator
- MRNA 47.66
- GMED 49.90
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.